Onset of alveolar recirculation in the developing lungs and its consequence on nanoparticle deposition in the pulmonary acinus.
The structure of the gas exchange region of the human lung (the pulmonary acinus) undergoes profound change in the first few years of life. In this paper, we investigate numerically how the change in alveolar shape with time affects the rate of nanoparticle deposition deep in the lung during postnatal development. As human infant data is unavailable, we use a rat model of lung development. The process of postnatal lung development in the rat is remarkably similar to that of the human, and the structure of the rat acinus is indistinguishable from that of the human acinus. The current numerical predictions support our group's recent in vivo findings, which were also obtained by using growing rat lung models, that nanoparticle deposition in infants is strongly affected by the change in the structure of the pulmonary acinus. In humans, this major structural change occurs over the first 2 yr of life. Our current predictions would suggest that human infants at the age of ∼ 2 yr might be most at risk to the harmful effects of air pollution. Our results also suggest that dose estimates for inhalation therapies using nanoparticles, based on fully developed adult lungs with simple body weight scaling, are likely to overestimate deposition by up to 55% for newborns and underestimate deposition by up to 17% for 2-yr-old infants.
Molecular and Integrative Physiological Sciences, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts; and Deptartment of Mechanical Engineering, Manhattan College, Riverdale, New York.
Frank S
FS
Henry
Molecular and Integrative Physiological Sciences, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts; and atsuda@hsph.harvard.edu.
Akira
A
Tsuda
D000375:Aging / Q000502:physiology; D000397:Air Pollution / Q000009:adverse effects; D000465:Algorithms; D000818:Animals; D001826:Body Fluids / Q000502:physiology; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008168:Lung / Q000254:growth & development* / Q000378:metabolism; D053758:Nanoparticles / Q000378:metabolism*; D011247:Pregnancy; D011650:Pulmonary Alveoli / Q000254:growth & development* / Q000502:physiology*; D011652:Pulmonary Circulation / Q000502:physiology*; D051381:Rats
alveolus; chaos; nanoparticles